← Back to Search

Corticosteroid

Steroid Injections for Trigger Finger

N/A
Recruiting
Led By Kevin Zuo, MD, MASc
Research Sponsored by Kevin Zuo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have a diagnosis of trigger finger (can be any of the 5 digits)
Be 18 years of age or older
Must not have
Decline to obtain a CSI for trigger finger management
Receiving multiple CSI for trigger finger management at the appointment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at 0 hours post-injection
Awards & highlights

Summary

This trial compares the pain associated with steroid injections for trigger finger when given from the front/palm side of the hand versus the back/dorsal side. The study aims to determine if injections from the

Who is the study for?
This trial is for individuals with trigger finger, a condition where a finger gets stuck in a bent position. Participants should be those who haven't had relief from other treatments and are suitable candidates for steroid injections.
What is being tested?
The study compares two methods of administering steroid injections to treat trigger finger: one through the back/dorsal side of the hand, which may be less painful, and the standard front/palm side injection.
What are the potential side effects?
Potential side effects include pain at the injection site, possible infection, temporary numbness or tingling in the injected area, and rarely tendon damage.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with trigger finger.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I choose not to get a corticosteroid injection for my trigger finger.
Select...
I am getting several steroid injections for my trigger finger.
Select...
I have had surgery or CSI on the affected finger.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at 0 hours, 4 hours, and 24 hours post-injection
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at 0 hours, 4 hours, and 24 hours post-injection for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Numerical Rating Scale (NRS) - Pain
Short-Form McGill Pain Questionnaire (SFMPQ) - Present Pain Intensity (PPI)
Visual Analogue Scale (VAS) - Pain
Secondary study objectives
Sensory Assessment - Light Touch
Sensory Assessment - Pain

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Dorsal Webspace ApproachExperimental Treatment1 Intervention
A dorsal approach involves passing the needle with a 1:1 triamcinolone and lidocaine mixture in the dorsal webspace skin aiming just palmar to the proximal phalanx bone such that the needle is directed into the flexor tendon sheath at the A1 annular pulley.
Group II: Palmar ApproachActive Control1 Intervention
Standard approach for injecting the 1:1 triamcinolone and lidocaine mixture involves the needle passing through the cutaneous and subcutaneous layers of the palmar skin surface and into the flexor tendon sheath at the A1 annular pulley.

Find a Location

Who is running the clinical trial?

Kevin ZuoLead Sponsor
Kevin Zuo, MD, MAScPrincipal InvestigatorUniversity Health Network, Toronto
~40 spots leftby Feb 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top